Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

ith non-GAAP financial measures, investors are provided with a more meaningful understanding of our ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators the Company uses as a basis for evaluating operational performance, allocating resources and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. To the extent this release contains historical non-GAAP financial measures, the Company has also provided corresponding GAAP financial measures for comparative purposes. Reconciliation between certain GAAP and non-GAAP measures is provided below.

About PharmacyclicsPharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several research molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 Having access ... is an uphill battle in many corners of the ... rural farming community in northwestern Bolivia where many have ... a group from Fairfield University’s School of Engineering has ... Unidad Academica Campesina (UAC), “the united college for the ...
(Date:10/31/2014)... (PRWEB) October 30, 2014 Two ... America were hosted by Charm Sciences at its ... their week in the US, the participants discussed ... control, hygiene management, and process verification, and received ... , This was the first visit to the ...
(Date:10/31/2014)... Dallas, Texas (PRWEB) October 31, 2014 ... report on Global and China Biocides industry. The ... classification, application, and industry chain structure as well ... market analysis, including China’s domestic market as well ... economic situation analysis. The report on the Chinese ...
(Date:10/31/2014)... ENVIRON , an international environmental, ... Dr. Harvey Clewell III has rejoined the firm ... with senior professionals in ENVIRON’s Health Sciences practice. ... The Hamner Institutes for Health Sciences (The Hamner) ... is Director, Center for Human Health Assessment. , ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 3Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 2Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 3
... University a six-year, $16.2 million grant for support of ... of the oldest interdisciplinary research centers in the nation. ... a scientific research program, is one of six Materials ... successfully renew support from the NSF this fiscal year. ...
... Laureate Biopharmaceutical Services, Inc. announced today that their ... Food and Drug Administration (FDA) to submit electronic common ... 4 gigabyte test submission comprising CMC, preclinical and clinical ... in record time. The endorsement complements Laureate,s recent approval ...
... HUYA Bioscience International, a leader in ... partnership with the Zhejiang Chinese Medical University Life ... global drug development of China,s novel Traditional Chinese ... to bring productive synergy between the two parties. ...
Cached Biology Technology:Collaborative science and engineering 2FDA Approves Electronic Common Technical Document (eCTD) for Laureate's Regulatory Submissions 2FDA Approves Electronic Common Technical Document (eCTD) for Laureate's Regulatory Submissions 3HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College 2HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College 3
(Date:10/31/2014)... Dr. John Schoggins , Assistant Professor of Microbiology ... New Innovator Award from the National Institutes of Health ... can harbor numerous viruses without becoming sick. , ... is one of 85 awards given under the High ... The New Innovator Awards were created to support highly ...
(Date:10/31/2014)... Thomas Bugnyar and his team have been studying ... the Northern Austrian Alps for years. They observed ... such as grooming and playing. However, they also ... by a third individual. Although in about 50 ... and broke up the two affiliating ravens, intervening ...
(Date:10/30/2014)... available in German . ... our fellow humans to behave socially? This is one ... game theory. Previous studies assumed that it is almost ... from the Max Planck Institute for Evolutionary Biology have ... influence on the cooperative behaviour of others. However, the ...
Breaking Biology News(10 mins):UT Southwestern Microbiologist awarded prestigious NIH research grant 2Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4
... as men, but estrogen might not be the reason. Testosterone, ... findings in the lab of Florida State University researcher Mohamed ... was awarded a five-year, $1.8 million grant from the National ... anxiety. His research team also is working to identify the ...
... industry with an annual turnover of more than SEK 500 ... the malaria medication sold there could be ineffective or even ... a technique that could resolve the situation. In ... It will resemble a small briefcase, in which a pharmacist, ...
... Lizards are an important indicator species for understanding the ... crucial index for evaluating species health, but lizards are ... problem of spontaneous tail loss when lizards are in ... of evaluating these lizards. Dr. Shai Meiri of Tel ...
Cached Biology News:Why does anxiety target women more? FSU researcher awarded $1.8 million grant to find out 2Problem of fake medicines in developing countries could be solved 2Getting a tail up on conservation? 2
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
Request Info...
Mouse Anti-Human MCAF-(MCP-1)...
Gastric Carcinoma Marker [BY-1 (3H11)]...
Biology Products: